Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMOV2ZD)

Drug Name
C188-9 Drug Info
Synonyms
QDCJDYWGYVPBDO-UHFFFAOYSA-N; UNII-KZ3DLD11RQ; KZ3DLD11RQ; AC1LQFBK; MLS006011646; SCHEMBL16394007; CHEMBL3392776; MolPort-000-644-242; N-(1B; ZINC1154831; AKOS001673470; MCULE-7568979350; NCGC00262829-02; SMR004703404; EU-0081697; AB00117290-01; C-188-9; N-[4-hydroxy-3-(2-hydroxynaphthalen-1-yl)naphthalen-1-yl]-4-methoxybenzenesulfonamide; N-[4-hydroxy-3-(2-hydroxy-1-naphthyl)-1-naphthyl]-4-methoxy-1-benzenesulfonamide; Benzenesulfonamide, N-(1',2-dihydroxy(1,2'-binaphthalen)-4'-yl)-4-methoxy-; 432001-19-9
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
1324494
CAS Number
CAS 432001-19-9
TTD Drug ID
DMOV2ZD

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting STAT3 messenger RNA (STAT3 mRNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-STAT3 DMDTNFB Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
ISIS 113187 DM4E6Y8 Discovery agent N.A. Investigative [3]
ISIS 113176 DM5QEP4 Discovery agent N.A. Investigative [3]
ISIS 113209 DMGVN7A Discovery agent N.A. Investigative [3]
ISIS 113210 DMZWH6E Discovery agent N.A. Investigative [3]
ISIS 17148 DMPZ9D3 Discovery agent N.A. Investigative [3]
ISIS 17152 DME7VZG Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
STAT3 messenger RNA (STAT3 mRNA) TTHJT3X STAT3_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
3 US patent application no. 7,098,192, Antisense oligonucleotide modulation of STAT3 expression.